LA JOLLA, CA, USA, August 27, 2020 /EINPresswire.com/ -- CureMetrix, a global leader in artificial intelligence (AI) for medical imaging, today announced a collaboration with Ambra Health, makers of the leading cloud-based, medical image management suite. The collaboration includes CureMetrix solutions cmTriage™ and cmAssist® to augment the Ambra Health suite of services.
cmTriage is the first FDA-cleared AI-based triage solution for mammography in the U.S. It helps radiologists triage, sort and prioritize mammography worklists based on suspicious cases that may need immediate attention. Studies have shown that with cmTriage, radiologists can realize up to a 30% reduction in mammography reading time, while supporting the overall practice to streamline workload.
Ambra Health’s best-in-class medical image management suite is used by the world’s leading medical facilities. Ambra Suite consolidates multiple imaging systems with one flexible, customizable, and interoperable cloud platform that lets providers access imaging securely anytime, anywhere. Once imaging has been freed from departmental silos, CDs, and complex VPN networks, the utilization of data for academic research, AI and machine learning initiatives, and improved interoperability become a reality. Through its Solution Directory, Ambra has established a network of innovative imaging partners like CureMetrix, which allows providers to launch leading imaging AI and analysis tools seamlessly from the Ambra platform.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
CureMetrix is also conducting studies across the globe to expand its AI solutions to help identify, mark and score anomalies in breast cancer screening. In studies published in the Journal of Digital Imaging, CureMetrix cmAssist AI-CAD was able to demonstrate the ability to reduce false positives by 69% over traditional CAD and help radiologists improve their breast cancer detection rate on average 27%, without increasing recall rates.
“We work with healthcare providers of all sizes to improve medical imaging processes and workflows through technology innovation," said Andrew Duckworth, VP of Business Development at Ambra Health. “Partnering with CureMetrix extends access for our customers to AI-based innovations that improve workflows in breast imaging for radiologists, hospital systems, radiology centers, and the patients they serve.”
“Breast cancer detection is complex, and to navigate that complexity radiologists need data-driven information and the most innovative tools to make better clinical decisions,” said Kevin Harris, president of CureMetrix. “With their focus on delivering better care through better technology, joining forces with Ambra Health is a great example of how partnering with innovators helps make healthcare excellence a reality.”